Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease. The main cause of NAFLD is insulin resistance; therefore, it is necessary to assess liver injury in patients with overweight and insulin resistance-related complications. The two main forms of primary NAFLD, steatosis and steatohepatitis (NASH), most likely represent distinct conditions. At present, the diagnosis of NASH presents drawbacks, including the lack of consensus regarding diagnostic criteria, sampling variability, cost and the invasiveness of the procedure. Based on a critical assessment of the literature, this article aims to determine whether the diagnosis of NASH is clinically useful, and whether it is feasible with noninvasive strategies instead of liver biopsy. A noninvasive diagnosis of NASH would facilitate screening and monitoring of populations at risk, as well as the conduct of therapeutic trials.
Ratziu
Vlad
V
Université Pierre et Marie Curie, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpêtrière, INSERM UMRS_893, CdR Saint-Antoine, Paris, France. vratziu@teaser.fr
Martin
Laurence
L
Fedchuk
Larysa
L
Poynard
Thierry
T